EVENTS

2024/05/02
ƒ[ƒuƒ‰ƒtƒBƒbƒVƒ…“Ő«Œ€‹†‚Ι‚¨‚―‚ιŽ”ˆη•iŽΏŠΗ—‚̏d—v«

2024/05/01
high-throughput individual zebrafish screening

2024/04/26
ƒ[ƒuƒ‰ƒtƒBƒbƒVƒ…‘n–ς‚Μ’·Š‚Ζ‰Ϋ‘θ

2024/04/25
discovery of stanniocalcin1 as cardiotoxic defence gene

2024/04/24
Tumour Angiogenesis in Patient-Deriveved Xenograft Zebarafish Model

tPatient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening

                     
2021/10/13

BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.

ŠΦ˜AƒŠƒ“ƒN

ŽOd‘εŠw‘εŠw‰@ˆγŠwŒnŒ€‹†‰ΘƒVƒXƒeƒ€ƒY–ς—Šw

biojapan2021

ŠΦ˜Aƒtƒ@ƒCƒ‹

Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening